Devyser Diagnostics Ownership

DVYSR Stock   128.50  5.00  4.05%   
Devyser Diagnostics holds a total of 16.01 Million outstanding shares. Devyser Diagnostics AB shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.12 percent of Devyser Diagnostics outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that almost three hundred fourty thousand nine hundred thirty-six invesors are currently shorting Devyser Diagnostics expressing very little confidence in its future performance.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Devyser Diagnostics AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Devyser Stock Ownership Analysis

About 68.0% of the company shares are held by company insiders. The book value of Devyser Diagnostics was currently reported as 27.66. The company recorded a loss per share of 2.11. Devyser Diagnostics had not issued any dividends in recent years. To learn more about Devyser Diagnostics AB call Ulf Klangby at 46 8 56 21 58 50 or check out https://www.devyser.com.

Devyser Diagnostics Outstanding Bonds

Devyser Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Devyser Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Devyser bonds can be classified according to their maturity, which is the date when Devyser Diagnostics AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Devyser Stock Analysis

When running Devyser Diagnostics' price analysis, check to measure Devyser Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devyser Diagnostics is operating at the current time. Most of Devyser Diagnostics' value examination focuses on studying past and present price action to predict the probability of Devyser Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devyser Diagnostics' price. Additionally, you may evaluate how the addition of Devyser Diagnostics to your portfolios can decrease your overall portfolio volatility.